Atlas Trials

Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma

Clinical trial NCT01979276 · TERMINATED

Trial details

NCT number
NCT01979276
Sponsor
Weill Medical College of Cornell University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-11-01
Primary completion
2016-10-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.